139 related articles for article (PubMed ID: 26359562)
1. Palliation of Extensive Metastatic Bone Disease With 223Ra-Dichloride α-Particle Therapy in a Patient With Malignant Hereditary Paraganglioma-Pheochromocytoma Syndrome With SDHB Mutation.
Makis W; McCann K; McEwan AJ; Sawyer MB
Clin Nucl Med; 2016 Feb; 41(2):144-7. PubMed ID: 26359562
[TBL] [Abstract][Full Text] [Related]
2. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
[TBL] [Abstract][Full Text] [Related]
3. Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation.
Makis W; McCann K; McEwan AJ; Sawyer MB
Clin Nucl Med; 2016 Mar; 41(3):204-6. PubMed ID: 26359568
[TBL] [Abstract][Full Text] [Related]
4. Malignant bladder pheochromocytoma with SDHB genetic mutation.
Maeda M; Funahashi Y; Katoh M; Fujita T; Tsuruta K; Gotoh M
Aktuelle Urol; 2013 Sep; 44(5):381-2. PubMed ID: 23807799
[TBL] [Abstract][Full Text] [Related]
5. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride.
Pandit-Taskar N; Larson SM; Carrasquillo JA
J Nucl Med; 2014 Feb; 55(2):268-74. PubMed ID: 24343987
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.
Pacilio M; Ventroni G; De Vincentis G; Cassano B; Pellegrini R; Di Castro E; Frantellizzi V; Follacchio GA; Garkavaya T; Lorenzon L; Ialongo P; Pani R; Mango L
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):21-33. PubMed ID: 26266887
[TBL] [Abstract][Full Text] [Related]
7. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
Baysal BE; Maher ER
Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
[TBL] [Abstract][Full Text] [Related]
8. Multiple paraganglioma syndrome type 4 due to succinate dehydrogenase B mutation: diagnostic and therapeutic challenges of a skull base paraganglioma masquerading as nasopharyngeal cancer.
Alzahrani AS; Alshaikh O; Faiyaz-Ul-Haque M; Abalkhail H; Al-Dayel F; Hindi HA
Endocr Pract; 2010; 16(3):452-8. PubMed ID: 20061288
[TBL] [Abstract][Full Text] [Related]
9. A Novel SDHB IVS2-2A>C Mutation Is Responsible for Hereditary Pheochromocytoma/Paraganglioma Syndrome.
Yamanaka M; Shiga K; Fujiwara S; Mizuguchi Y; Yasuda S; Ishizawa K; Saiki Y; Higashi K; Ogawa T; Kimura N; Horii A
Tohoku J Exp Med; 2018 Jun; 245(2):99-105. PubMed ID: 29925701
[TBL] [Abstract][Full Text] [Related]
10. [Bone-specific therapy with radium-223 dichloride : Castration-resistant prostate cancer with symptomatic bone metastases].
Tauber R; Gschwend J; Scheidhauer K; Eiber M; Krönke M
Urologe A; 2017 Jan; 56(1):24-31. PubMed ID: 28058455
[TBL] [Abstract][Full Text] [Related]
11. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
12. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
Bruland ØS; Nilsson S; Fisher DR; Larsen RH
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6250s-6257s. PubMed ID: 17062709
[TBL] [Abstract][Full Text] [Related]
13. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene.
Young AL; Baysal BE; Deb A; Young WF
J Clin Endocrinol Metab; 2002 Sep; 87(9):4101-5. PubMed ID: 12213855
[TBL] [Abstract][Full Text] [Related]
14. A rare hereditary and metastatic paraganglioma involved in both spermatic cord and testis.
Luo S; Liu Z; Zhou Z
Endocrine; 2019 Jul; 65(1):217-218. PubMed ID: 30798430
[No Abstract] [Full Text] [Related]
15. Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4.
Gill AJ; Pachter NS; Clarkson A; Tucker KM; Winship IM; Benn DE; Robinson BG; Clifton-Bligh RJ
N Engl J Med; 2011 Mar; 364(9):885-6. PubMed ID: 21366490
[No Abstract] [Full Text] [Related]
16. SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma.
Kunst HP; Rutten MH; de Mönnink JP; Hoefsloot LH; Timmers HJ; Marres HA; Jansen JC; Kremer H; Bayley JP; Cremers CW
Clin Cancer Res; 2011 Jan; 17(2):247-54. PubMed ID: 21224366
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
18. Four generations of SDHB-related disease: complexities in management.
Srirangalingam U; LeCain M; Tufton N; Akker SA; Drake WM; Metcalfe K
Fam Cancer; 2017 Apr; 16(2):279-282. PubMed ID: 27896548
[TBL] [Abstract][Full Text] [Related]
19. Radium-223 dichloride therapy in breast cancer with osseous metastases.
Takalkar A; Paryani B; Adams S; Subbiah V
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26581701
[TBL] [Abstract][Full Text] [Related]
20. Failure of MIBG scan to detect metastases in SDHB-mutated pediatric metastatic pheochromocytoma.
Sait S; Pandit-Taskar N; Modak S
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28409892
[No Abstract] [Full Text] [Related]
[Next] [New Search]